Literature DB >> 16716602

Expression and purification of the Mycobacterium tuberculosis complex-restricted antigen CFP21 to study its immunoprophylactic potential in mouse model.

Ajay Grover1, Mir Fayaz Ahmed, Indu Verma, Pawan Sharma, G K Khuller.   

Abstract

Secreted proteins encoded by different regions of difference (RDs) from the genome of Mycobacterium tuberculosis have been considered as attractive candidates for vaccination against tuberculosis owing to their absence in most BCG strains. In this study, the structural gene for the RD2 locus encoding protein CFP21 was PCR amplified and expressed as a fusion protein with hexahistidine residues in Escherichia coli. Expression of CFP21 in E. coli under transcriptional regulation of the T7 promoter yielded a protein located within inclusion bodies. The inclusion bodies were solubilized in the presence of 8M urea and the protein was purified to homogeneity under denaturing conditions at low pH using nitrilotriacetic acid (Ni-NTA) affinity chromatography. The denatured protein was renatured by gradient dialysis against a decreasing concentration of urea. The purified protein was shown to have esterase activity. CFP21 protein was evaluated for immunogenicity in C57BL/6J mice. We observed an elevated T cell proliferative response and production of IFN-gamma and IL-12 (p40). CFP21 also induced an optimum level of cytotoxic T cell activity and induced a strong humoral response as indicated by higher levels of specific IgG1 and IgG2a antibody isotypes. In addition, a moderate level of protection was observed against experimental tuberculosis. This is the first report describing esterase activity of the M. tuberculosis complex-restricted protein CFP21 and its protective potential against experimental tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16716602     DOI: 10.1016/j.pep.2006.03.010

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  10 in total

1.  Region of difference 2 contributes to virulence of Mycobacterium tuberculosis.

Authors:  Robert A Kozak; David C Alexander; Reiling Liao; David R Sherman; Marcel A Behr
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

2.  An improved whole-blood gamma interferon assay based on the CFP21-MPT64 fusion protein.

Authors:  Ruiling Fu; Chun Wang; Chunwei Shi; Mengji Lu; Zhengming Fang; Jia Lu; Fang Wang; Xionglin Fan
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

3.  Profiling Esterases in Mycobacterium tuberculosis Using Far-Red Fluorogenic Substrates.

Authors:  Katie R Tallman; Samantha R Levine; Kimberly E Beatty
Journal:  ACS Chem Biol       Date:  2016-05-23       Impact factor: 5.100

4.  Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis.

Authors:  Nicholas P West; Teresa M Wozniak; Jesus Valenzuela; Carl G Feng; Alan Sher; Jose M C Ribeiro; Warwick J Britton
Journal:  Vaccine       Date:  2008-05-23       Impact factor: 3.641

5.  Interaction of alveolar epithelial cells with CFP21, a mycobacterial cutinase-like enzyme.

Authors:  Pooja Vir; Dheeraj Gupta; Ritesh Agarwal; Indu Verma
Journal:  Mol Cell Biochem       Date:  2014-08-05       Impact factor: 3.396

6.  Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines.

Authors:  Hannah Priyadarshini Gideon; Katalin Andrea Wilkinson; Tige R Rustad; Tolu Oni; Heinner Guio; Robert Andrew Kozak; David R Sherman; Graeme Meintjes; Marcel A Behr; Hans Martin Vordermeier; Douglas Brownlee Young; Robert John Wilkinson
Journal:  PLoS Pathog       Date:  2010-12-23       Impact factor: 6.823

7.  RD antigen based nanovaccine imparts long term protection by inducing memory response against experimental murine tuberculosis.

Authors:  Mairaj Ahmed Ansari; Swaleha Zubair; Anjum Mahmood; Pushpa Gupta; Aijaz A Khan; Umesh D Gupta; Ashish Arora; Mohammad Owais
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

8.  Mycobacterium tuberculosis lipolytic enzymes as potential biomarkers for the diagnosis of active tuberculosis.

Authors:  Belinda Brust; Mélanie Lecoufle; Edouard Tuaillon; Luc Dedieu; Stéphane Canaan; Viviane Valverde; Laurent Kremer
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

9.  Heterogeneity among Homologs of Cutinase-Like Protein Cut5 in Mycobacteria.

Authors:  Deepshikha Verma; Lahari Das; Vandana Gambhir; Kanak Lata Dikshit; Grish C Varshney
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

10.  Fusion peptide constructs from antigens of M. tuberculosis producing high T-cell mediated immune response.

Authors:  Shaista Arif; Mohsina Akhter; Aasia Khaliq; Muhammad Waheed Akhtar
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.